Could a Two-Drug combo beat whipworm in kids?

NCT ID NCT07661316

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial tests whether combining two drugs—albendazole and ivermectin—works better than the standard single drug for treating whipworm infection in schoolchildren aged 6 to 15 in Honduras. Participants receive a single dose of either placebo, albendazole alone, albendazole plus ivermectin, or a fixed-dose combination tablet. The study measures cure rates and side effects, aiming to find a more effective treatment for this common intestinal worm infection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
albendazole and ivermectin
What this could lead to
If successful, this combination could offer a more effective, single-dose treatment for whipworm and other soil-transmitted worms, simplifying control programs in affected regions.
What could go wrong
This is a single trial in one region, and results may not apply elsewhere. The combination may cause more side effects than standard treatment, and cure rates may still be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASCARIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Instituto de Investigaciones en Microbiología, Facultad De Ciencias, Universidad Nacional Autónoma de Honduras

    Tegucigalpa, 11101, Honduras

More trials for these conditions

Other studies related to the condition(s) this trial covers.